Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 2;7(12):e2450108.
doi: 10.1001/jamanetworkopen.2024.50108.

Buprenorphine Injection Among Rural Persons Who Inject Drugs

Kaitlin A Zinsli  1 , Elenore P Bhatraju  2 , Judith Feinberg  3 , Thomas J Stopka  4 , Peter D Friedmann  5 , William Zule  6 , Hannah L F Cooper  7 , April M Young  8 , P Todd Korthuis  9 , Mai T Pho  10 , Wiley D Jenkins  11 , William C Miller  12 , Vivian F Go  13 , David W Seal  14 , Ryan P Westergaard  15 , Rob J Fredericksen  2 , Joseph A Delaney  1   2 , Judith I Tsui  2
Affiliations

Buprenorphine Injection Among Rural Persons Who Inject Drugs

Kaitlin A Zinsli et al. JAMA Netw Open. .
No abstract available

Plain language summary

This cross-sectional study investigates buprenorphine injection, including factors associated with this use, among rural individuals who inject drugs.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Friedmann reported receiving grants from Indivior during the conduct of the study. Dr Zule reported receiving grants from RTI International during the conduct of the study. Dr Korthuis reported receiving grants from the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) during the conduct of the study. Dr Seal reported receiving grants from the NIDA outside the submitted work. No other disclosures were reported.

References

    1. Bozinoff N, Tardelli VS, Rubin-Kahana DS, Le Foll B. Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review. Harm Reduct J. 2022;19(1):113. doi:10.1186/s12954-022-00695-5 - DOI - PMC - PubMed
    1. Cicero TJ, Ellis MS, Chilcoat HD. Understanding the use of diverted buprenorphine. Drug Alcohol Depend. 2018;193:117-123. doi:10.1016/j.drugalcdep.2018.09.007 - DOI - PubMed
    1. McLean K, Kavanaugh PR. “They’re making it so hard for people to get help:” motivations for non-prescribed buprenorphine use in a time of treatment expansion. Int J Drug Policy. 2019;71:118-124. doi:10.1016/j.drugpo.2019.06.019 - DOI - PubMed
    1. Kiang MV, Barnett ML, Wakeman SE, Humphreys K, Tsai AC. Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States. Drug Alcohol Depend. 2021;228:109081. doi:10.1016/j.drugalcdep.2021.109081 - DOI - PMC - PubMed
    1. Jenkins RA, Whitney BM, Nance RM, et al. ; Rural Opioid Initiative . The Rural Opioid Initiative Consortium description: providing evidence to understand the fourth wave of the opioid crisis. Addict Sci Clin Pract. 2022;17(1):38. doi:10.1186/s13722-022-00322-5 - DOI - PMC - PubMed